Skip to content
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Neurology · HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis

Symptoms and the Daily Impact of HAM/TSP

At a Glance

HAM/TSP causes slowly progressive stiffness and weakness in both legs, with balance and walking changes, bladder or bowel problems, and pain. Symptoms can worsen temporarily with fatigue, stress, heat, or illness, while arm and thinking functions are often preserved.

Living with HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) means navigating a range of physical changes that primarily affect the lower half of your body [1]. While the disease moves slowly, its impact on daily life—from how you walk to how often you need a restroom—can be significant.

Changes in Mobility and Leg Function

The hallmark of HAM/TSP is spastic paraparesis, which is a medical way of describing progressive stiffness and weakness in both legs [2]. For many, the first sign is a change in gait; you might feel like your legs are “heavy,” or you may find yourself tripping more often [3].

  • Spasticity: This is not just weakness, but an increase in muscle tone that makes your legs feel tight or stiff. It can make movements like climbing stairs or getting out of a car feel clumsy [4].
  • Balance: Many patients experience “wobbliness” or poor balance long before they need a walking aid. This is due to the spinal cord’s difficulty sending quick signals to the muscles that keep you upright [5].
  • The Osame Motor Disability Score (OMDS): Doctors often use this 13-point scale to track how your mobility changes over years. It ranges from 0 (normal walking) to 13 (completely bedridden). Many patients remain in the middle of this scale for decades, using a cane or a walker to stay mobile [3][6].

Bladder and Bowel Challenges

Urinary issues are among the most common and distressing symptoms of HAM/TSP, affecting over 90% of patients in some clinical studies [7]. Because these symptoms are often subtle at first, they may go undertreated.

Common patterns include:

  • Urgency and Frequency: Feeling a sudden, overwhelming need to go to the bathroom, or needing to go many times throughout the day and night (nocturia) [8].
  • Incomplete Emptying: Feeling like your bladder isn’t fully empty even after you’ve finished. This happens because the muscles that control the bladder may not “sync” correctly with the sphincters that let urine out (detrusor-sphincter dyssynergia) [7][9].
  • Incontinence: Accidental leaking of urine, which can happen if the bladder becomes overactive [4].
  • Constipation: Bowel movements may become less frequent or harder to pass due to changes in the nerve signals to the colon [10].

Understanding Pain and Sensation

Pain is a significant symptom for many patients and usually falls into two categories:

  • Neuropathic Pain: Pain that comes directly from damaged nerves in the spinal cord. It is frequently described as burning, tingling, or “electric shocks” in the legs and feet [11].
  • Musculoskeletal Pain: Chronic lower back pain is very common [12]. This is often driven by the extra strain on your back muscles as they overcompensate for your stiff or weak legs, as well as nerve irritation [9].

What Usually Stays the Same?

It is important to know that HAM/TSP is very specific in where it strikes the nervous system.

  • Upper Body: Your arms and hands are usually spared, meaning they typically retain their normal strength and coordination [2].
  • Cognitive Function: Unlike some other neurological conditions, HAM/TSP does not typically affect your memory, thinking, or personality [2].

Note: While upper body and cognitive functions are usually preserved, they are not guaranteed to be. If you experience new symptoms in your arms, hands, vision, or thinking, report them to your doctor immediately. They need to be evaluated to determine if they are related to HAM/TSP or caused by a different condition.

Fluctuation vs. Progression

One of the most confusing parts of living with a chronic neurological condition is that you will have “bad days” and “better days.” This is daily fluctuation, not necessarily a sign that the disease is getting worse.

  • Triggers: Symptoms like stiffness and balance issues can temporarily flare up if you are tired, stressed, overheated, or fighting a minor illness like a urinary tract infection or a cold [13].
  • True Progression: This is measured over months and years, not days. If you find that a task you could do six months ago (like walking to the mailbox) is now consistently impossible, that represents true disease progression [3][6].

Common questions in this guide

What symptoms are common with HAM/TSP?
HAM/TSP commonly causes progressive stiffness and weakness in both legs, which can change walking and balance. It may also cause urinary urgency, frequent urination, incomplete emptying, leakage, constipation, burning or electric-shock pain, and lower-back pain.
Why do my HAM/TSP symptoms change from one day to the next?
Fatigue, stress, overheating, and minor illnesses such as a cold or urinary tract infection can temporarily worsen stiffness or balance. A bad day does not necessarily mean the disease has progressed; lasting changes are usually judged over months or years.
How can HAM/TSP affect bladder and bowel function?
HAM/TSP can disrupt the nerve signals that coordinate the bladder and bowel. Symptoms may include sudden urgency, frequent daytime or nighttime urination, incomplete emptying, leakage, and constipation.
Could a urodynamic study help evaluate HAM/TSP bladder symptoms?
A urodynamic study checks how the bladder stores and releases urine and whether it empties properly. Your clinician may recommend it when urgency, leakage, or a feeling of incomplete emptying needs further evaluation.
What does the Osame Motor Disability Score tell me?
The Osame Motor Disability Score is a 13-point scale used to track mobility over time. A score of 0 represents normal walking, while 13 represents being completely bedridden; intermediate scores reflect varying degrees of walking difficulty.
What kinds of pain can HAM/TSP cause?
HAM/TSP pain may be neuropathic, causing burning, tingling, or electric-shock sensations in the legs and feet. It may also be musculoskeletal, such as chronic lower-back pain related to strain from stiff or weak legs.
Should I report new symptoms in my hands, arms, or thinking?
Arm and hand strength and coordination, as well as memory, thinking, and personality, are usually preserved in HAM/TSP. New symptoms in the arms, hands, vision, or thinking should be reported promptly because they may need evaluation for another cause or a different neurologic problem.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my current symptoms, what is my score on the Osame Motor Disability Score (OMDS)?
  2. 2.Should I have a formal urodynamic study to see if my bladder is emptying properly?
  3. 3.How can I tell if my leg weakness is caused by 'spasticity' (stiffness) or actual muscle loss?
  4. 4.Are my lower back and leg pains considered 'neuropathic,' and how does that change my treatment options?
  5. 5.Is it normal to have some numbness in my hands, or does that mean we need to investigate a different cause?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (13)
  1. 1

    Neuroimmunology of Human T-Lymphotropic Virus Type 1-Associated Myelopathy/Tropical Spastic Paraparesis.

    Nozuma S, Jacobson S

    Frontiers in microbiology 2019; (10()):885 doi:10.3389/fmicb.2019.00885.

    PMID: 31105674
  2. 2

    Association Between HTLV-1 Genotypes and Risk of HAM/TSP.

    Saito M

    Frontiers in microbiology 2019; (10()):1101 doi:10.3389/fmicb.2019.01101.

    PMID: 31156605
  3. 3

    Nation-wide epidemiological study of Japanese patients with rare viral myelopathy using novel registration system (HAM-net).

    Coler-Reilly AL, Yagishita N, Suzuki H, et al.

    Orphanet journal of rare diseases 2016; (11(1)):69 doi:10.1186/s13023-016-0451-x.

    PMID: 27225443
  4. 4

    HTLV-1 Proviral Load Absolute RT-qPCR Development for Assessing on Clinical Outcomes in HAM/TSP Patients.

    Ariaee N, Abbasnia S, Sabet F, et al.

    Reports of biochemistry & molecular biology 2023; (12(3)):393-402 doi:10.61186/rbmb.12.3.393.

    PMID: 38618262
  5. 5

    Balance Impairments in Patients with Human T-Cell Lymphotropic Virus Type 1 Infection.

    Vasconcelos BHB, Callegari B, Costa KHA, et al.

    Scientific reports 2019; (9(1)):11456 doi:10.1038/s41598-019-47920-z.

    PMID: 31391511
  6. 6

    Real-world clinical course of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Japan.

    Tsutsumi S, Sato T, Yagishita N, et al.

    Orphanet journal of rare diseases 2019; (14(1)):227 doi:10.1186/s13023-019-1212-4.

    PMID: 31639014
  7. 7

    Urodynamic findings and vibegron effects on neurogenic lower urinary tract dysfunction caused by human T-cell leukemia virus type I-associated myelopathy/tropical spastic paraparesis.

    Kumekawa T, Akaihata H, Natsuya H, et al.

    IJU case reports 2024; (7(6)):438-441 doi:10.1002/iju5.12773.

    PMID: 39498183
  8. 8

    Neurological Manifestations in Human T-Cell Lymphotropic Virus Type 1 (HTLV-1)-Infected Individuals Without HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis: A Longitudinal Cohort Study.

    Tanajura D, Castro N, Oliveira P, et al.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2015; (61(1)):49-56 doi:10.1093/cid/civ229.

    PMID: 25820277
  9. 9

    Nanomicellar Curcumin Supplementation Improves the Clinical Manifestations of HAM/TSP Patients.

    Mohammadi A, Yazdi SZ, Poursina Z, et al.

    Advances in experimental medicine and biology 2021; (1328()):347-359 doi:10.1007/978-3-030-73234-9_22.

    PMID: 34981488
  10. 10

    Self-management of HTLV-1-associated myelopathy/tropical spastic paraparesis in Japan: A qualitative study.

    Yamaguchi S, Yatsushiro R

    PLoS neglected tropical diseases 2026; (20(3)):e0014055 doi:10.1371/journal.pntd.0014055.

    PMID: 41855158
  11. 11

    Pain, psychoaffective symptoms, and quality of life in human T cell lymphotropic virus type 1 (HTLV-1): a cross-sectional study.

    Dos Santos DN, Sá KN, Queirós FC, et al.

    Journal of neurovirology 2021; (27(6)):838-848 doi:10.1007/s13365-020-00914-4.

    PMID: 33405200
  12. 12

    Immunopathogenesis and Cellular Interactions in Human T-Cell Leukemia Virus Type 1 Associated Myelopathy/Tropical Spastic Paraparesis.

    Aghajanian S, Teymoori-Rad M, Molaverdi G, Mozhgani SH

    Frontiers in microbiology 2020; (11()):614940 doi:10.3389/fmicb.2020.614940.

    PMID: 33414779
  13. 13

    Immunovirological markers in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

    Enose-Akahata Y, Jacobson S

    Retrovirology 2019; (16(1)):35 doi:10.1186/s12977-019-0499-5.

    PMID: 31783764

This page is for informational purposes only and does not constitute medical advice. A clinician should evaluate new neurologic symptoms, worsening mobility, pain, or bladder and bowel changes.

Get notified when new evidence is published on Tropical spastic paraparesis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.